Antenatal lamivudine to reduce perinatal hepatitis B transmission: A cost-effectiveness analysis

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 3, 2012, Pages 231.e1-231.e7

  Nayeri, Unzila A ^a   Werner, Erika F ^b   Han, Christina S ^a   Pettker, Christian M ^a   Funai, Edmund F ^c   Thung, Stephen F ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

hepatitis B; lamivudine; perinatal transmission; pregnancy

Indexed keywords

LAMIVUDINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HIDDEN MARKOV MODEL; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; PERINATAL INFECTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY;

EID: 84865799507     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.06.001     Document Type: Article

References (49)

1. H. Te, D. Jensen Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 1 2010 1 21 vii
2. J. Perz, G. Armstrong, L. Farrington, Y.J.F. Hutin, B. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 4 2006 529 538
3. J.E. Maynard Hepatitis B: global importance and need for control Vaccine 1990 S18 S20
4. Centers for Disease Control and Prevention Disease burden from hepatitis A, B and C; 2011 http://www.cdc.gov/hepatitis/Statistics/index.htm Accessed Aug. 18, 2011
5. E. Mast, C. Weinbaum, A. Fiore A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults MMWR Recomm Rep 55 RR-16 2006 1 33
6. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 86: viral hepatitis in pregnancy Obstet Gynecol 4 2007 941 956
7. E. Mast, H. Margolis, A. Fiore A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents MMWR Recomm Rep 54 RR-16 2005 1 31
8. W.J. Edmunds, G.F. Medley, D.J. Nokes, A.J. Hall, H.C. Whittle The influence of age on the development of the hepatitis B carrier state Proc Roy Soc B: Biol Sc 1337 1993 197 201
9. T. Tran Management of hepatitis B in pregnancy: weighing the options Cleve Clin J Med 2009 S25 S29
10. B.J. McMahon, W.L. Alward, D.B. Hall Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state J Infect Dis 4 1985 599 603
11. K.C. Hyams Risks of chronicity following acute hepatitis B virus infection: a review Clin Infect Dis 4 1995 992 1000
12. V.C. Wong, H.M. Ip, H.W. Reesink Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study Lancet 8383 1984 921 926
13. R.P. Beasley, L.Y. Hwang, G.C. Lee Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine Lancet 8359 1983 1099 1102
14. C.E. Stevens, P.E. Taylor, M.J. Tong Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 19 1987 2612 2616
15. Y. Ghendon Perinatal transmission of hepatitis B virus in high-incidence countries J Virol Meth 1987 1 2 69-79
16. W.F. Li, R. Jiang, Z. Weiz, Y. Li Clinical effect and safety of lamivudine in interruption of chronic HBV maternal to infant transmission Chin Hepatol 2006 106 107
17. M. Shi, X. Li, J. He, Y. Yang, H. Hou, Y. Zhuang Study of lamivudine in interruption of HBV intrauterine infection Clin Med Chin 2005 77 78
18. Z.H. Han, Y.H. Chen, L.W. Li, X.W. Sun, Y.G. Sun, H. Zhao Effect and safety of preventing HBV vertical transmission by lamivudine treatment Chin J Intern Med 378 2005
19. H.F. Feng, S.F. Zhang Effect on interruption of hepatitis B virus vertical transmission by lamivudine J Appl Clin Pediatr 2007 1019 1020
20. G.J. Xiang, J.W. Sun, S.Q. Jiang, X.B. Hu, A.L. Qu Evaluation of therapeutic effect in HBV vertical transmission by lamivudine treatment combined with active-passive immunization for pregnant women Chin Prac Med 2007 14 16
21. J.H. Yang The clinical observation of effect of lamivudine on blocking mother to infant transmission of chronic HBV Int Med Health Guide News 2008 76 78
22. S. Yang, M. Liu, L. Wang Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women Zhonghua Fu Chan Ke Za Zhi 5 2008 329 331
23. Z. Shi, X. Li, Y. Yang, L. Ma Clinical research on the interruption of mother to child transmission of HBV - a randomized, double-blind, placebo-control study United for Site 6th Annual Global Health Conference 2009 Yale University New Haven, CT
24. W. Xu, Y. Cui, L. Wang Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study J Viral Hepat 2 2009 94 103
25. X. Li, Y. Yang, H. Hou Interruption of HBV intrauterine transmission: a clinical study World J Gastroenterol 7 2003 1501 1503
26. Z. Shi, Y. Yang, L. Ma, X. Li, A. Schreiber Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis Obstet Gynecol 1 2010 147 159
27. Micromedex www.thompsonhc.com 2012 Accessed April 20, 2012
28. J. King, J. Tsevat, J. Lave, M. Roberts Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation Med Decis Making 25 2005 667 677
29. M. Huang, A.S.F. Lok Natural history of hepatitis B and outcomes after liver transplantation Clin Liver Dis 3 2003 521 536
30. M. Kennedy, S. Alexopoulos Hepatitis B virus infection and liver transplantation Curr Opin Organ Transplant 3 2010 310 315
31. M. Gambarin-Gelwan Hepatitis B in pregnancy Clin Liver Dis 4 2007 945 963
32. C.A.K.Y. Chong, A. Gulamhussein, E.J. Heathcote Health-state utilities and quality of life in hepatitis C patients Am J Gastroenterol 3 2003 630 638
33. S. Post, N. Sodhi, C. Peng, K. Wan, H. Pollack A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective Health Aff 2 2011 340 348
34. F. Kanwal, M. Farid, P. Martin Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis Am J Gastroenterol 9 2006 2076 2089
35. D. McLernon, J. Dillon, P. Donnan Health-state utilities in liver disease: a systematic review Med Decis Making 4 2008 582 592
36. H. Dakin, A. Bentley, G. Dusheiko Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B Value Health 8 2010 922 933
37. J. O'Leary, R. Lepe, G. Davis Indications for liver transplantation Gastroenterology 6 2008 1764 1776
38. Cardinal health: average wholesale prices www.cardinal.com Accessed July 26, 2011
39. Red book of average wholesale drug prices 2010th ed. 2010 Thompson Medical Economics Montvale, NJ
40. W.G. Bennett, Y. Inoue, J.R. Beck, J.B. Wong, S.G. Pauker, G.L. Davis Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C Ann Intern Med 10 1997 855 865
41. B. Plunkett, W. Grobman Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis Obstet Gynecol 3 2004 998 1003
42. T. Lee, D. Veenstra, U. Iloeje, S. Sullivan Cost of chronic hepatitis B infection in the United States J Clin Gastroenterol 10 Suppl 3 2004 S144 S147
43. S. Saab, M. Ham, M. Stone, C. Holt, M. Tong Decision analysis model for hepatitis B prophylaxis one year after liver transplantation Liver Transplant 4 2009 413 420
44. Z. Shi, X. Li, L. Ma, Y. Yang Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission- A meta-analysis Int J Infect Dis 7 2010 e622 e634
45. Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2011 http://www.apregistry.com/forms/interim report.pdf Accessed Aug. 23, 2011
46. E. Unal, G. Lazenby, A. Lintzenich, K. Simpson, R. Newman, L. Goetzl Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission Obstet Gynecol 3 2011 655 662
47. H. Yim, A. Lok Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005 Hepatology 2 Suppl 1 2006 S173 S181
48. Organ Procurement Transplant Network http://optn.transplant.hrsa.gov/ ar2009/904a-rec-dgn-li.htm 2009 Accessed Aug. 12, 2011
49. United network for organ sharing, 2011 www.unos.org Accessed Aug. 12, 2011